Shanghai Yizhong Pharmaceutical Co., Ltd. (688091.SS)
CNY 40.96
(2.24%)
CNY 40.96
(2.24%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 82.42 Million | 110.78 Million | -48.78 Million | -20.21 Million | -23.9 Million | -10.68 Million |
| Net Income | 161.55 Million | 142.85 Million | -3.99 Million | -21.84 Million | -315.22 Million | -12.58 Million |
| Depreciation & Amortization | 8.17 Million | 6.42 Million | 6.59 Million | 6.16 Million | 5 Million | 4.54 Million |
| Deferred income taxes | -3.99 Million | 6.7 Million | -5.28 Million | - | -295.49 Million | - |
| Stock-based compensation | 27.27 Million | 783.6 Thousand | - | - | 295.49 Million | - |
| Change in working capital | -50.15 Million | -9.3 Million | -40.9 Million | 312.6 Thousand | -4.45 Million | 1.44 Million |
| Other non-cash items | 33.35 Million | -36.67 Million | -10.48 Million | -4.84 Million | 290.76 Million | -4.08 Million |
| Investing Cash Flow | 77.21 Million | 502.27 Million | -785.62 Million | 16.99 Million | -50.8 Million | -16.06 Million |
| Investments in PPE | -8.78 Million | -35.88 Million | -3.14 Million | -5 Million | -47.57 Million | -3.46 Million |
| Acquisitions | -86 Million | 2.56 Billion | 1.51 Billion | 40.00 | - | - |
| Investment purchases | -1.33 Billion | -2.56 Billion | -1.51 Billion | -40.00 | - | - |
| Sales/Maturities of investments | 1.41 Billion | 26.86 Million | 6.25 Million | 4.13 Million | 3.62 Million | 4.86 Million |
| Other Investing Activities | 86 Million | 511.29 Million | -788.73 Million | 17.86 Million | -6.85 Million | -17.45 Million |
| Financing Cash Flow | 44 Million | -17.24 Million | 944.65 Million | 3.25 Million | 71.7 Million | 27.2 Million |
| Debt repayment | -44 Million | -16.75 Million | -13.5 Million | -3.25 Million | - | - |
| Dividends payments | -43.4 Million | -491.42 Thousand | -588.86 Thousand | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | -76 Million | - | - | - |
| Other Financing Activities | 44 Million | -16.75 Million | 944.65 Million | 3.25 Million | 71.7 Million | 27.2 Million |
| Accounts receivables | -69.19 Million | -28.45 Million | -21.49 Million | -556.8 Thousand | 244.3 Thousand | 212 Thousand |
| Accounts payables | 30.42 Million | 17.72 Million | -3.81 Million | -383.8 Thousand | -4.25 Million | 3.23 Million |
| Inventory | -11.38 Million | -5.27 Million | -10.3 Million | 1.25 Million | -444.62 Thousand | -2 Million |
| Other working capital | 26.42 Million | 6.7 Million | -5.28 Million | -18.00 | -7.61 | 3.44 Million |
| Cash at beginning of period | 710.38 Million | 110.43 Million | 191.47 Thousand | 154.03 Thousand | 3.16 Million | 2.71 Million |
| Cash at end of period | 914.76 Million | 706.24 Million | 110.43 Million | 191.47 Thousand | 154.03 Thousand | 3.16 Million |
| Capital Expenditure | -8.78 Million | -35.88 Million | -3.14 Million | -5 Million | -47.57 Million | -3.46 Million |
| Effect of forex changes on cash | 743.25 Thousand | 0.47 | - | - | - | -0.18 |
| Net cash flow / Change in cash | 204.38 Million | 595.81 Million | 110.23 Million | 37.44 Thousand | -3.01 Million | 453.68 Thousand |
| Free Cash Flow | 73.63 Million | 74.9 Million | -51.92 Million | -25.21 Million | -71.48 Million | -14.14 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 161.17 Thousand | 5.33 Million | 29.17 Million | 30.93 Million | 161.55 Million | 26.51 Million |
| Depreciation & Amortization | - | 2.84 Million | 2.84 Million | 2.32 Million | 8.17 Million | -3.43 Million |
| Deferred income taxes | - | - | - | 53.3 Million | -3.99 Million | - |
| Stock-based compensation | - | 9.78 Million | - | 27.27 Million | 27.27 Million | - |
| Change in working capital | - | -9.71 Million | - | -80.57 Million | -50.15 Million | 60.41 Million |
| Other non-cash items | 20.27 Million | -11.53 Million | 2.12 Million | 20.34 Million | 33.35 Million | -72.5 Million |
| Investing Cash Flow | 411.33 Million | -615.14 Million | 13.18 Million | 42.89 Million | 77.21 Million | 21.09 Million |
| Investments in PPE | -35.67 Million | -10.14 Million | -6.81 Million | -107.34 Thousand | -8.78 Million | -1.01 Million |
| Acquisitions | 10.51 Thousand | - | - | -1.00 | -86 Million | -539.2 Million |
| Investment purchases | 1.47 Billion | -1.47 Billion | - | -1.33 Billion | -1.33 Billion | 539.2 Million |
| Sales/Maturities of investments | -885 Million | 560 Million | 325 Million | 1.41 Billion | 1.41 Billion | 4.11 Million |
| Other Investing Activities | -138 Million | 305 Million | -305 Million | -43 Million | 86 Million | 18 Million |
| Financing Cash Flow | -48.15 Million | -71.47 Million | 8.8 Million | 67.28 Million | 44 Million | 20 Million |
| Debt repayment | -20.1 Million | -22.1 Million | -9.1 Million | -23.9 Million | -44 Million | -20.1 Million |
| Dividends payments | - | -49.37 Million | -294.59 Thousand | -27.02 Thousand | -43.4 Million | -95.43 Thousand |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -28.05 Million | -49.37 Million | -294.59 Thousand | 43.38 Million | 44 Million | 40.19 Million |
| Accounts receivables | - | -7.64 Million | - | -69.19 Million | -69.19 Million | 62.37 Million |
| Accounts payables | - | - | - | - | 30.42 Million | - |
| Inventory | - | -2.06 Million | - | -11.38 Million | -11.38 Million | -1.95 Million |
| Other working capital | - | - | - | - | - | - |
| Cash at beginning of period | 267.51 Million | 974.24 Million | 914.76 Million | 809.62 Million | 710.38 Million | 751.43 Million |
| Cash at end of period | 651.13 Million | 267.51 Million | 974.24 Million | 914.76 Million | 914.76 Million | 799.41 Million |
| Capital Expenditure | -35.67 Million | -10.14 Million | -6.81 Million | -107.34 Thousand | -8.78 Million | -1.01 Million |
| Effect of forex changes on cash | - | - | - | -5.33 Million | 743.25 Thousand | -4.11 Million |
| Net cash flow / Change in cash | 383.61 Million | -706.73 Million | 59.48 Million | 105.13 Million | 204.38 Million | 47.97 Million |
| Free Cash Flow | -15.23 Million | -19.19 Million | 24.48 Million | 192.65 Thousand | 73.63 Million | 9.96 Million |
300786
600302
SYSCHEM
MMNGF
TRINITYLEA
NOBDF